Lacosamide Tablet, Film Coated
Product Images NDC 82804-991

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 82804-991). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

A bar chart comparing mean seizure frequency per 28 days across placebo and lacosamide dosages of 100 mg, 150 mg, and 200 mg. The chart shows statistically significant seizure frequency reductions for lacosamide at all doses versus placebo in three separate studies.*

FDA Label Image

Chemical Structure (Lacosamide 01)

Chemical structure of the active ingredient Lacosamide, depicted as a 2D molecular diagram showing its arrangement of atoms and bonds, including carbon, oxygen, nitrogen, and hydrogen atoms, with a benzene ring attached via an amine group.*

FDA Label Image

Figure 2 (Lacosamide 03)

A cumulative responder rate graph showing the proportion of patients by responder rate for Lacosamide and placebo groups across three studies. The Y-axis represents responder rate ranging from -100% (worsening) to 100% (improvement). The X-axis shows percent of patients, decreasing from 100 to 0. Four lines represent Placebo and Lacosamide doses of 200 mg/day, 400 mg/day, and 600 mg/day, comparing patient responses.*

FDA Label Image

82804-990-30 (Lacosamide 04)

Lacosamide 50 mg film-coated tablets packaging label indicating quantity of 30 tablets. The label states each tablet contains 50 mg of lacosamide USP. It includes product and manufacturer details, with Proficient Rx LP as the packaging labeler and ScieGen Pharmaceuticals, Inc. as the manufacturer. The tablets are described as pink, oval, and film-coated with specific debossing. Storage instructions and a caution to keep medication out of reach of children are also present.*

FDA Label Image

82804-991-30 (Lacosamide 05)

Label for Lacosamide 100 mg film-coated tablets by Proficient Rx LP. The package contains 30 tablets. The label states that each yellow, oval tablet is debossed with 'SG' on one side and '193' on the other. It is manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY, and stored at 20°-25°C. The product is classified as Schedule V (C-V) and is Rx only.*

FDA Label Image

82804-992-30 (Lacosamide 06)

Label for Lacosamide 150 mg film-coated tablets by Proficient Rx LP, containing 30 tablets. The beige, oval tablets are debossed with 'SG' on one side and '194' on the other. Manufactured by ScieGen Pharmaceuticals, Inc., Hauppauge, NY. The label includes storage instructions and a Controlled Substance Schedule V (C-V) designation.*

FDA Label Image

82804-993-30 (Lacosamide 07)

Lacosamide 200 mg film-coated tablets label showing prescription drug information. The bottle contains 30 tablets. Tablets are blue, oval, debossed with 'SG' on one side and '195' on the other. Manufactured by ScieGen Pharmaceuticals and packaged by Proficient Rx LP.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.